FUS Etoposide for DMG

Clinical trial NCT05762419 · RECRUITING

Trial details

NCT number: NCT05762419
Sponsor: Columbia University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma Diffuse Midline Glioma, H3 K27M-Mutant

Start date: 2023-06-05
Primary completion: 2026-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.